1 false false false false false false false false false false true false false false false false false No description of principal activity 2024-02-29 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 14636071 2024-02-29 2025-02-28 14636071 2025-02-28 14636071 2024-02-28 14636071 2023-02-02 2024-02-28 14636071 2024-02-28 14636071 2023-02-01 14636071 bus:Director1 2024-02-29 2025-02-28 14636071 core:AfterOneYear 2025-02-28 14636071 core:ShareCapital 2025-02-28 14636071 core:ShareCapital 2024-02-28 14636071 core:RetainedEarningsAccumulatedLosses 2025-02-28 14636071 bus:SmallEntities 2024-02-29 2025-02-28 14636071 bus:AuditExemptWithAccountantsReport 2024-02-29 2025-02-28 14636071 bus:SmallCompaniesRegimeForAccounts 2024-02-29 2025-02-28 14636071 bus:PrivateLimitedCompanyLtd 2024-02-29 2025-02-28 14636071 bus:AbridgedAccounts 2024-02-29 2025-02-28
COMPANY REGISTRATION NUMBER: 14636071
Vaviri UK Ltd
Filleted Unaudited Abridged Financial Statements
28 February 2025
Vaviri UK Ltd
Abridged Statement of Financial Position
28 February 2025
2025
2024
Note
£
£
Current assets
Debtors
100
Cash at bank and in hand
755
----
----
755
100
----
----
Net current assets
755
100
----
----
Total assets less current liabilities
755
100
Creditors: amounts falling due after more than one year
53,832
--------
----
Net (liabilities)/assets
( 53,077)
100
--------
----
Capital and reserves
Called up share capital
100
100
Profit and loss account
( 53,177)
--------
----
Shareholders (deficit)/funds
( 53,077)
100
--------
----
These abridged financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the abridged statement of comprehensive income has not been delivered.
For the year ending 28 February 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its abridged financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of abridged financial statements .
All of the members have consented to the preparation of the abridged statement of comprehensive income and the abridged statement of financial position for the year ending 28 February 2025 in accordance with Section 444(2A) of the Companies Act 2006.
Vaviri UK Ltd
Abridged Statement of Financial Position (continued)
28 February 2025
These abridged financial statements were approved by the board of directors and authorised for issue on 11 December 2025 , and are signed on behalf of the board by:
Mr A Comfort
Director
Company registration number: 14636071
Vaviri UK Ltd
Notes to the Abridged Financial Statements
Year ended 28 February 2025
1. General information
The company is a private company limited by shares, registered in England. The address of the registered office is C/- Sable International,, 5th Floor, 18 St. Swithin's Lane, London, EC4N 8AD, England.
2. Statement of compliance
These abridged financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The abridged financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The abridged financial statements are prepared in sterling, which is the functional currency of the entity.
Going concern
The directors have prepared the accounts on a going concern basis as they have concluded that this is an appropriate basis given the financial position of the company, the risks and uncertainties being faced and the fact that confirmation has been received from the shareholders that they will continue to provide financial support, if required, to enable the company to continue trading for a period of at least 12 months from the date of approval of these financial statements.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2024: Nil).